ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
… An innovative biotech company advancing our proprietary Axiomer RNA-editing platform technology. We are ProQR We are … and common diseases. We focus on advancing our proprietary Axiomer™ RNA-editing platform technology. ProQR has offices …
… treatments for people with rare genetic diseases. Axiomer RNA base editing At ProQR we invented the Axiomer™ technology that enables single base editing to …
At ProQR, we are dedicated to improving the lives of patients and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology.
… transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today reported its … and target engagement/biomarker strategy. AX-0810 uses Axiomer’s ability to modulate protein function by targeting …
… transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced … demonstrating the breadth and versatility of our Axiomer RNA editing technology," said Gerard Platenburg, …
… momentum toward the clinic Accelerated development of Axiomer™ for CNS applications via new research partnership … on RNA editing, ProQR made important progress with Axiomer, our ADAR-mediated RNA editing technology platform,” …
… First Quarter 2025 Operating and Financial Results Axiomer™ ADAR-mediated RNA editing pipeline advancing across … transformative RNA therapies based on its proprietary Axiomer RNA editing technology platform, today reported its …
… transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the … appointments support the advancement of the Company’s Axiomer platform technology and pipeline of RNA editing …
